Idera Pharmaceutical (NASDAQ:IDRA)’s share price plunged -1.93% or -0.04 to reach at $2.03 during previous trading session. A total of 1.25 Million shares exchanged hands, whereas the company’s average trading volume stands at 1.96 Million shares. Idera Pharmaceutical (NASDAQ:IDRA) has a market capitalization of $385.98 Million and most recently 190.14 Million outstanding shares have been calculated.

According to sentiments of 4 analysts the mean estimates of short term price target for the company’s stock is marked at $5.5. The most optimistic analyst sees the stock reaching $8 while the most conventional predicts the target price at $4.

In terms of Buy/Sell recommendations, 4 analysts have a consensus rating of 1 on the shares of Idera Pharmaceutical (NASDAQ:IDRA). Out of rating recommendations 2 have given the stock a Buy while 4 recommend the stock as Outperform. 0 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

Idera Pharmaceutical (NASDAQ:IDRA)’s distance from 20 day simple moving average is 0.0614 along with distance from 50 day simple moving average of 1.92 whereas its distance from 200 day simple moving average is 2.07. Idera Pharmaceutical (NASDAQ:IDRA)’s price distance from 52-week high is -29.27 and from 52-week low is 53.79. The stock hit its 52-week high price on 10/11/17, and 52-week low price on 10/26/17. The stock’s 52-week price fluctuated within the range of $2.87 – $1.32.

Idera Pharmaceutical (NASDAQ:IDRA)’s shares climbed 3.05% in the past week and soared 5.73% in the last 4 weeks, historically the stock illustrate that its six months performance stands at 4.1% while its year to date performance is at -3.79%.

While taking a glance at financials, we can look at a number of key indicators. Idera Pharmaceutical (NASDAQ:IDRA) has a Return on Assets (ROA) of 0. The company currently has a Return on Equity (ROE) of 0 and a Return on Investment (ROI) of -61.6. Average true range (ATR-14) of the company sets at 0.11, along with its weekly and monthly volatility of 5.52% and 5.66% respectively. Relative strength index (RSI-14) for Idera Pharmaceutical (NASDAQ:IDRA) is at 54.28. Beta value of the stock stands at 2.36.

The company’s price to free cash flow for trailing twelve months is 0. Its quick ratio for most recent quarter is 11.5 along with current ratio for most recent quarter of 11.5. Total debt to equity ratio of Idera Pharmaceutical (NASDAQ:IDRA) for most recent quarter is 0 whereas long term debt to equity ratio for most recent quarter is 0.

Shares of FS Investment Corp (NYSE:FSIC) plunged -0.68% or -0.05 to reach at $7.35 during previous trading session. FS Investment Corp (NYSE:FSIC) has a market capitalization of $1.81 Billion and most recently 245.73 Million outstanding shares have been calculated. A total of 1.32 Million shares exchanged hands, whereas the company’s average trading volume stands at 1.73 Million shares.

According to 5 analysts FS Investment Corp (NYSE:FSIC)’s price will reach at $8.35 during 52 weeks. Stock’s minimum price target estimates has been figured out at $7.5 while the maximum price target forecast is established at $9.

According to the recommendations from 4 analysts stock has mean rating of 2.67 on the shares of FS Investment Corp (NYSE:FSIC). Out of rating recommendations 1 have given the stock a Buy while 0 recommend the stock as Outperform. 5 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

Shares of FS Investment Corp (NYSE:FSIC) slipped -0.68% in the past week and soared 0.68% in the last 4 weeks, historically the stock illustrate that its six months performance stands at -10.91% while its year to date performance is at 0%.

FS Investment Corp (NYSE:FSIC)’s 52-week price fluctuated within the range of $10.00 – $7.05. Its price distance from 52-week high is -26.5 and from 52-week low is 4.26. The stock hit its 52-week high price on 03/16/17, and 52-week low price on 02/06/18. FS Investment Corp (NYSE:FSIC)’s distance from 20 day simple moving average is0.0027 along with distance from 50 day simple moving average of 7.45 whereas its distance from 200 day simple moving average is 7.88.

Total debt to equity ratio of FS Investment Corp (NYSE:FSIC) for most recent quarter is 0.75 whereas long term debt to equity ratio for most recent quarter is 0.75. The company’s price to free cash flow for trailing twelve months is 27.2. Its quick ratio for most recent quarter is 0 along with current ratio for most recent quarter of 0.

Average true range (ATR-14) of the company sets at 0.18, along with its weekly and monthly volatility of 1.78% and 2.35% respectively. Relative strength index (RSI-14) for FS Investment Corp (NYSE:FSIC) is at 48.07. Beta value of the stock stands at 0.98. FS Investment Corp (NYSE:FSIC) has a Return on Assets (ROA) of 4.4. The company currently has a Return on Equity (ROE) of 7.9 and a Return on Investment (ROI) of 5.1.